
Carla J. Myers
Examiner (ID: 5220, Phone: (571)272-0747 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1655, 1682, 1643, 1609, 1621, 1654, 1807, 1634, 1644 |
| Total Applications | 2312 |
| Issued Applications | 1000 |
| Pending Applications | 336 |
| Abandoned Applications | 987 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19318712
[patent_doc_number] => 20240240255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => BICYCLE CONJUGATES SPECIFIC FOR NECTIN-4 AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/021748
[patent_app_country] => US
[patent_app_date] => 2021-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18021748
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/021748 | BICYCLE CONJUGATES SPECIFIC FOR NECTIN-4 AND USES THEREOF | Aug 16, 2021 | Pending |
Array
(
[id] => 18243560
[patent_doc_number] => 20230075871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => METHOD FOR DETERMINING RADIATION EXPOSURE WITH SENSITIVE AND SPECIFIC GENE EXPRESSION SIGNATURES
[patent_app_type] => utility
[patent_app_number] => 17/402550
[patent_app_country] => US
[patent_app_date] => 2021-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14572
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17402550
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/402550 | METHOD FOR DETERMINING RADIATION EXPOSURE WITH SENSITIVE AND SPECIFIC GENE EXPRESSION SIGNATURES | Aug 14, 2021 | Abandoned |
Array
(
[id] => 17370393
[patent_doc_number] => 20220025445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => GENOTYPING OF POLYPLOIDS
[patent_app_type] => utility
[patent_app_number] => 17/402037
[patent_app_country] => US
[patent_app_date] => 2021-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20825
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17402037
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/402037 | GENOTYPING OF POLYPLOIDS | Aug 12, 2021 | Pending |
Array
(
[id] => 17705036
[patent_doc_number] => 20220205042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => Molecular Signatures for Distinguishing Liver Transplant Rejections or Injuries
[patent_app_type] => utility
[patent_app_number] => 17/401643
[patent_app_country] => US
[patent_app_date] => 2021-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23296
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17401643
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/401643 | Molecular Signatures for Distinguishing Liver Transplant Rejections or Injuries | Aug 12, 2021 | Pending |
Array
(
[id] => 18701650
[patent_doc_number] => 11788151
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => C-RAF mutants that confer resistance to RAF inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/399563
[patent_app_country] => US
[patent_app_date] => 2021-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 33
[patent_no_of_words] => 16308
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17399563
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/399563 | C-RAF mutants that confer resistance to RAF inhibitors | Aug 10, 2021 | Issued |
Array
(
[id] => 18583256
[patent_doc_number] => 20230265516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => SINGLE NUCLEOTIDE POLYMORPHISMS AND TREATMENT OF INFLAMMATORY CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/040976
[patent_app_country] => US
[patent_app_date] => 2021-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20107
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040976
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040976 | SINGLE NUCLEOTIDE POLYMORPHISMS AND TREATMENT OF INFLAMMATORY CONDITIONS | Aug 5, 2021 | Pending |
Array
(
[id] => 18709612
[patent_doc_number] => 20230332233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => USE OF microRNA (miRNA) MARKER IN PREPARATION OF PRODUCT FOR EVALUATING THERAPEUTIC EFFECT OF OLANZAPINE IN TREATMENT OF SCHIZOPHRENIA (SZ) AND KIT
[patent_app_type] => utility
[patent_app_number] => 18/025639
[patent_app_country] => US
[patent_app_date] => 2021-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5577
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025639
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/025639 | Use of microRNA (miRNA) marker in preparation of product for evaluating therapeutic effect of olanzapine in treatment of schizophrenia (SZ) and kit | Aug 3, 2021 | Issued |
Array
(
[id] => 18676789
[patent_doc_number] => 20230314419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => TARGET MEASUREMENT METHOD, TARGET MEASUREMENT DEVICE, TARGET MEASUREMENT APPARATUS, AND TARGET MEASUREMENT KIT
[patent_app_type] => utility
[patent_app_number] => 18/023249
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11641
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18023249
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/023249 | TARGET MEASUREMENT METHOD, TARGET MEASUREMENT DEVICE, TARGET MEASUREMENT APPARATUS, AND TARGET MEASUREMENT KIT | Jul 29, 2021 | Pending |
Array
(
[id] => 17228984
[patent_doc_number] => 20210355540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => ASSESSMENT OF RISK OF ANEUPLOIDY
[patent_app_type] => utility
[patent_app_number] => 17/390620
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13009
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17390620
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/390620 | ASSESSMENT OF RISK OF ANEUPLOIDY | Jul 29, 2021 | Abandoned |
Array
(
[id] => 17657509
[patent_doc_number] => 20220177974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => GENETIC SIGNATURES TO PREDICT PROSTATE CANCER METASTASIS AND IDENTIFY TUMOR AGGRESSIVENESS
[patent_app_type] => utility
[patent_app_number] => 17/390674
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35656
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17390674
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/390674 | GENETIC SIGNATURES TO PREDICT PROSTATE CANCER METASTASIS AND IDENTIFY TUMOR AGGRESSIVENESS | Jul 29, 2021 | Abandoned |
Array
(
[id] => 19051318
[patent_doc_number] => 20240093287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => METHODS AND COMPOSITIONS FOR REDUCING INDEX HOPPING
[patent_app_type] => utility
[patent_app_number] => 18/018401
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22167
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18018401
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/018401 | METHODS AND COMPOSITIONS FOR REDUCING INDEX HOPPING | Jul 29, 2021 | Abandoned |
Array
(
[id] => 17688237
[patent_doc_number] => 20220195529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => ISOFORMS OF GATA6 AND NKX2-1 AS MARKERS FOR DIAGNOSIS AND THERAPY OF CANCER AND AS TARGETS FOR ANTI-CANCER THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/386088
[patent_app_country] => US
[patent_app_date] => 2021-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 198
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17386088
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/386088 | ISOFORMS OF GATA6 AND NKX2-1 AS MARKERS FOR DIAGNOSIS AND THERAPY OF CANCER AND AS TARGETS FOR ANTI-CANCER THERAPY | Jul 26, 2021 | Abandoned |
Array
(
[id] => 17414412
[patent_doc_number] => 20220049316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => METHOD FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF BREAST CANCER METASTASIS
[patent_app_type] => utility
[patent_app_number] => 17/385568
[patent_app_country] => US
[patent_app_date] => 2021-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20045
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17385568
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/385568 | Method for the diagnosis, prognosis and treatment of breast cancer metastasis | Jul 25, 2021 | Issued |
Array
(
[id] => 17214892
[patent_doc_number] => 20210348229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => COMBINATORIAL DNA SCREENING
[patent_app_type] => utility
[patent_app_number] => 17/383273
[patent_app_country] => US
[patent_app_date] => 2021-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26485
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17383273
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/383273 | Combinatorial DNA screening | Jul 21, 2021 | Issued |
Array
(
[id] => 17357168
[patent_doc_number] => 20220017964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => Cornulin (CRNN) Variants And Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/378900
[patent_app_country] => US
[patent_app_date] => 2021-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17378900
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/378900 | Cornulin (CRNN) Variants And Uses Thereof | Jul 18, 2021 | Abandoned |
Array
(
[id] => 17197986
[patent_doc_number] => 20210338080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => ALZHEIMER'S DISEASE PERSONALIZED MEDICINE
[patent_app_type] => utility
[patent_app_number] => 17/378487
[patent_app_country] => US
[patent_app_date] => 2021-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18831
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17378487
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/378487 | Alzheimer's disease personalized medicine | Jul 15, 2021 | Issued |
Array
(
[id] => 17185552
[patent_doc_number] => 20210332437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => METHODS FOR NON-INVASIVE DETECTION OF TRANSPLANT HEALTH OR REJECTION
[patent_app_type] => utility
[patent_app_number] => 17/370646
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17370646
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/370646 | METHODS FOR NON-INVASIVE DETECTION OF TRANSPLANT HEALTH OR REJECTION | Jul 7, 2021 | Abandoned |
Array
(
[id] => 18612757
[patent_doc_number] => 20230279492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT
[patent_app_type] => utility
[patent_app_number] => 18/014814
[patent_app_country] => US
[patent_app_date] => 2021-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 83310
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014814
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/014814 | METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT | Jul 4, 2021 | Pending |
Array
(
[id] => 19332882
[patent_doc_number] => 20240247312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT
[patent_app_type] => utility
[patent_app_number] => 18/014801
[patent_app_country] => US
[patent_app_date] => 2021-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64999
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014801
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/014801 | METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT | Jul 4, 2021 | Pending |
Array
(
[id] => 17168837
[patent_doc_number] => 20210322507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => GENOTYPE-DIRECTED LOCAL DELIVERY OF TARGETED THERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 17/363897
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17363897
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/363897 | GENOTYPE-DIRECTED LOCAL DELIVERY OF TARGETED THERAPEUTICS | Jun 29, 2021 | Pending |